In a release issued under the same headline on Friday, August 16, 2024, by InnovAge, please note the staff count four years ago has been corrected from seven to 20 people. The revised release is as follows:
SACRAMENTO, Calif., Aug. 22, 2024 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. (“InnovAge”) (Nasdaq: INNV), an industry leader in providing comprehensive healthcare programs to predominantly dual-eligible seniors through the Program of All-inclusive Care for the Elderly (PACE), celebrated the fourth anniversary of its Sacramento, California center with community members, local representatives, businesses, healthcare providers, and other valued partners.
“The demand for affordable, reliable healthcare for seniors is growing rapidly,” said InnovAge President and CEO Patrick Blair. “Along with our Eskaton and Adventist Health joint-venture partners, we are proud to celebrate the continued growth of InnovAge PACE’s state-of-the-art senior center in Sacramento. PACE is more than just a health care plan. It’s about teams of dedicated professionals providing dual-eligible seniors, a vulnerable population, and their families a broad array of care and services to help them continue to live independently.”
“Four years ago, we were a staff of 20 people, serving a few participants (enrolled seniors), and managing the challenges of opening in the middle of a pandemic,” said Center Director Jenny Rojas-Singh. “Today, our staff has significantly increased to meet the needs of the hundreds of participants we now serve. It is a privilege of mine to see this center grow every day.”
InnovAge provides integrated healthcare and support services to seniors, and at no cost for Medicare and Medi-Cal-covered participants. The program takes a personalized approach encompassing transportation, in-home care, medication management, dental care, specialty care, physical, occupational, and speech therapy, exercise, social services, meals and nutrition, socialization, recreational activities, and more. InnovAge tailors healthcare services to each participant, through customized care plans developed in partnership with seniors, their loved ones, and the company’s healthcare providers, helping to empower seniors and promote independence and well-being.
At today’s celebration, InnovAge recognized several community partners who help seniors, the Latino community, and low-income families, with counseling, support services, and education. Guests were able to tour the center and interact with staff who shared senior healthcare tips and community resources. The InnovAge Sacramento PACE center includes five day rooms, a primary care clinic with 13 exam rooms, a dental suite, multiple patios, a therapy gym, full-service kitchen, large dining room, and more.
Media Contact
Lara Hazenfield
InnovAge Public Relations & Content Creation Manager
This email address is being protected from spambots. You need JavaScript enabled to view it.
720-884-7568
About InnovAge
InnovAge is a market leader in managing the care of high-cost, frail, and predominantly dual-eligible seniors through the Program of All-inclusive Care for the Elderly (PACE). With a mission of enabling older adults to age independently in their own homes for as long as safely possible, InnovAge’s patient-centered care model is designed to improve the quality of care its participants receive while reducing over-utilization of high-cost care settings. InnovAge believes its PACE healthcare model is one in which all constituencies — participants, their families, providers, and government payors — “win.” As of March 31, 2024, InnovAge served approximately 6,820 participants across 19 centers in six states. With the opening of its Orlando center April, InnovAge currently operates 20 centers. www.InnovAge.com.
This press release was published by a CLEAR® Verified individual.
Last Trade: | US$5.80 |
Daily Change: | -0.10 -1.69 |
Daily Volume: | 15,862 |
Market Cap: | US$786.600M |
October 11, 2024 September 16, 2024 September 10, 2024 April 24, 2024 |
C4 Therapeutics is pioneering a new class of small-molecule drugs that selectively destroy disease-causing proteins via degradation using the innate machinery of the cell. This targeted protein degradation approach offers advantages over traditional drugs, including the potential to treat a wider range of diseases...
CLICK TO LEARN MOREChimerix is on a mission to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases. The company is devoted to filling gaps in the treatment paradigm. Chimerix’s most advanced clinical-stage program is in development for H3 K27M-mutant glioma....
CLICK TO LEARN MOREEnd of content
No more pages to load
COPYRIGHT ©2023 HEALTH STOCKS HUB